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ABSTRACT Natriuretic peptides, produced in the heart,
bind to the natriuretic peptide receptor A (NPRA) and cause
vasodilation and natriuresis important in the regulation of
blood pressure. We here report that mice lacking a functional
Npr1 gene coding for NPRA have elevated blood pressures and
hearts exhibiting marked hypertrophy with interstitial fibro-
sis resembling that seen in human hypertensive heart disease.
Echocardiographic evaluation of the mice demonstrated a
compensated state of systemic hypertension in which cardiac
hypertrophy and dilatation are evident but with no reduction
in ventricular performance. Nevertheless, sudden death, with
morphologic evidence indicative in some animals of congestive
heart failure and in others of aortic dissection, occurred in all
15 male mice lacking Npr1 before 6 months of age, and in one
of 16 females in our study. Thus complete absence of NPRA
causes hypertension in mice and leads to cardiac hypertrophy
and, particularly in males, lethal vascular events similar to
those seen in untreated human hypertensive patients.
The precursor of atrial natriuretic peptide (ANP) is produced
and stored mainly in the right atrium of the heart. ANP formed
from this precursor is released in response to atrial stretch (1,
2). Once in the circulation, ANP binds to the natriuretic
peptide receptor A (NPRA, also known as guanylate cyclase
A or GC-A) mainly in the kidney, vascular tissue, and adrenal
gland. This binding induces an increase in intracellular cGMP
and initiates natriuresis, diuresis, and vasodilation, all of which
contribute to lowering blood pressure (3–5). ‘‘B-type’’ natri-
uretic peptide, a structurally related peptide mainly formed in
the cardiac ventricles, also acts through NPRA and has effects
similar to ANP. Several studies have suggested a relationship
between ANP and blood pressure. For example, the plasma
ANP levels in children of two normotensive parents are higher
than in children of one normotensive and one hypertensive
parent, especially at high levels of salt intake (6). The response
of circulating ANP to salt loading is also deficient in the
spontaneously hypertensive rat (7). Furthermore, genetic ma-
nipulations affecting ANP or NPRA synthesis lead to alter-
ations in the blood pressures of mice (8–10).
The role of the ANP-NPRA system in cardiac pathophysi-
ology is not well understood. Although expression of the genes
encoding ANP and ‘‘B-type’’ natriuretic peptide is markedly
increased in patients with hypertrophic or failing hearts, it is
unclear if this system is activated to play a protective role by
reducing the detrimental effects of high blood pressure, or if
it is simply a consequence of the hypertrophic changes occur-
ring in the heart. To study the role of NPRA in the regulation
of blood pressure and in the cardiovascular response to
sustained hypertension we have made mice completely lacking
this receptor. Our results demonstrate that NPRA deficiency
in mice leads to elevated blood pressures and, particularly in
males, to cardiac hypertrophy and sudden death.
MATERIALS AND METHODS
Gene Targeting. Three electroporations of embryonic stem
(ES) cells (E14TG2a) were carried out as described (11). The
targeting construct contained 59 and 39 fragments of mouse
strain 129 Npr1 (the gene coding for NPRA) genomic DNA
and a 2.4-kb insert composed of a 1.1-kb fragment from
pMC1neoPolyA (Stratagene) placed in an orientation oppo-
site to the transcription of Npr1 and an irrelevant 1.3-kb
HindIII fragment from approximately 6 kb downstream of
exon 22 of the Npr1 gene. The 59 region of homology was a
6.5-kb SalI–EagI fragment from upstream of exon 1. The 39
region of homology was a 1.4-kb PstI–HindIII fragment of
DNA that includes most of exons 2–4. Correctly targeted ES
cell clones were identified by the presence of a 5.5-kb hybrid-
izing band in addition to a 12-kb endogenous band in Southern
blots of ES cell DNA digested with BamHI and hybridized to
a PCR-derived probe for intron 4. Animals were derived from
the correctly targeted ES cells as previously described (12) and
handled under protocols approved by the institutional animal
care and use committees.
Western Blot Analysis. Whole kidneys from Npr1 2y2 or
wild type (1y1) mice were homogenized in a polytron in
ice-cold buffer containing 20 mM Na N-Tris[hydroxymethyl]-
methyl-2-aminoethanesulfonic acidy10 mM mannitol, pH
7.4y30 mg/ml phenylmethylsulfonyl f luoridey2 mg/ml leupep-
tiny16 mg/ml benzamidine. After an initial centrifugation at
800 3 g for 10 min, soluble and membrane fractions were
separated by centrifugation at 413,000 3 g for 1 hr at 4°C. The
particulate fractions were resuspended in the same buffer
containing 1% Triton X-100. Proteins (60 mg) in soluble and
membrane fractions were fractionated in 7.5% SDS-
polyacrylamide gels, transferred to Immobilon-P, and analyzed
by Western blotting as described (13). Antiserum 281 directed
against the rat NPRA extracellular domain was generated by
immunizing rabbits with polyhistidine-tagged NPRA (residues
242–493) and was purified after bacterial expression. No
NPRA-immunoreactive proteins were present in the soluble
fractions.
Photoaffinity Labeling of ANP Receptor. Plasma mem-
branes (200 mg) were incubated with 125I-4-azidobenzoyl ANP
in 250 ml of a reaction mixture containing 50 mM MgCl2, 0.5
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mgyml bacitracin, 1 mM phenylmethylsulfonyl f luoride, 1 mM
EDTA, 2 mM N-ethylmaleimide, 10 mgyml aprotinin, and 10
mgyml leupeptin for 60 min at 25°C in the dark as previously
described (14, 15). The reaction mixture then was photolyzed
on ice for 30 min with a 250-watt General Electric sun lamp at
about 10 cm. After photolysis, samples were washed twice in
reaction buffer without bacitracin and subjected to SDSy
PAGE. The receptor bands were localized by autoradiography.
Blood Pressure Measurements. Blood pressures were mea-
sured in conscious young adult male or female mice ranging
from 3 to 4 months of age by a noninvasive computerized
tail-cuff method (16) by an individual blinded to the genotypes
of the animals. After 7 days of training, the measurement was
made for each animal as the mean of at least six subsequent
sessions on each of 5 days. Blood pressures first were measured
in animals after 2 weeks on low salt chow (0.05% NaCl,
TD94025, Teklad, Madison WI). Animals then were placed on
an intermediate salt diet (2% NaCl, TD96037, Teklad) for an
additional 2 weeks and retrained and remeasured. Finally, the
animals were placed on a high-salt diet (8% NaCl, TD96038,
Teklad) and again trained, and blood pressures were mea-
sured. Statistical analysis was performed by using multiple
ANOVAs, with salt, gender, and genotype as variables.
Transthoracic Echocardiography and Hemodynamic Eval-
uation. Mice (3–4 months old) were anesthetized with ket-
amine (100 mgykg) and xylazine (2.5 mgykg) intraperitoneally,
the chest was shaved, and echocardiograms were obtained by
using an echocardiograph (Apogee CX, Interspec-ATL, Both-
ell, WA). The transducer (9 Mhz) was applied by using a
gel-filled standoff to obtain two-dimensional guided M-mode
tracings of a cross section of the left ventricular minor axis at
the tips of the papillary muscles. The details of these methods
and their reliability have been described (17). Several days
after echocardiographic evaluation, mice were reanesthetized,
and a 1.4 French high-fidelity micromanometer catheter (Mil-
lar Instruments, Houston, TX) was inserted into the right
carotid artery. After bilateral vagotomy (to limit counter
regulatory autonomic reflexes), the micromanometer was ad-
vanced retrograde into the left ventricle, and hemodynamic
measurements were recorded at baseline and 5 min after the
infusion of 1 ml of 0.7% saline. Continuous high-fidelity left
ventricle pressure was recorded simultaneously on an eight-
channel chart recorder and in digitized form at 2,000 Hz for
later analysis. Experiments were then terminated, hearts were
rapidly excised, and individual chambers were separated,
weighed, and frozen in liquid N2.
Plasma Renin Concentration. Arterial blood samples from
Npr1 2y2 and age-matched Npr1 1y1 litter mates under CO2
anesthesia were rapidly withdrawn into ice-cold microcentri-
fuge tubes containing EDTA, by using noncoated glass pi-
pettes, and immediately centrifuged to isolate plasma. Plasma
renin concentrations were determined by a radioimmunoassay
for angiotensin I as described (18).
RESULTS AND DISCUSSION
Elevated Blood Pressures in Mice Lacking Natriuretic
Peptide Receptor A. We used gene targeting in strain 129
embryonic stem cells to replace exon 1 and intron 1 of the gene
(19) coding for NPRA (Npr1 in mice) with a DNA fragment
containing a neomycin selectable marker (Fig. 1A). This
replacement disrupts the gene and removes 237 amino acids
from the N-terminal region of the ligand-binding domain,
generating a nonfunctional allele. Male chimeras generated
from the targeted embryonic stem cells were mated to
C57BLy6 (B6) females and transmitted the inactivated Npr1
gene to their F1 offspring. The 129yB6 F1 hybrids that were
Npr1 1y2 were intercrossed to obtain Npr1 2y2, 1y2, and
1y1 F2 generation animals, which were used for all of the
experiments reported here. At weaning, the three genotypes
were represented in normal Mendelian proportions. Kidney
membrane preparations from animals homozygous for the
Npr1 mutation (2y2) show no NPRA protein (135 kDa) by
Western blot analysis (Fig. 1B). Receptor-binding analysis
performed on lung membrane extracts (Fig. 1C) confirms the
absence of functional NPRA in the 2y2 animals. In contrast,
the amount of the natriuretic peptide receptor C remained
unchanged; this receptor binds natriuretic peptides but has no
guanylate cyclase activity and is thought to function in clear-
ance of the peptides (3).
The effects of Npr1 genotype on tail cuff blood pressures
were assessed by using Npr1 1y1 and 2y2 animals with three
concentrations of NaCl in their chow: 0.05% (low), 2% (in-
termediate), or 8% (high). The mean blood pressures of the
Npr1 2y2 animals of either sex and with all three salt intakes
were markedly higher than the pressures of Npr1 1y1 animals
(Fig. 2A). Homozygous mutants had an average increase in
blood pressure of 16 mmHg with the effect of genotype being
highly significant (P , 0.0001, by ANOVA). The blood
pressures of males of either genotype and on all three diets
were higher than the corresponding pressures for females
(average difference 10 mmHg) again with the difference being
highly significant (P , 0.0001). There were indications that the
effect of Npr1 genotype is greater in males than in females, but
the interaction of genotype and gender did not reach signifi-
cance (P 5 0.1). No significant effects of diet on the blood
pressures of mice of either sex and of either Npr1 genotype
were observed, although the mean blood pressures of the
Npr12y2 males on high salt (158 mmHg) were the highest of
FIG. 1. Targeted disruption of the Npr1 gene. (A) The top line
shows the structure of the Npr1 gene containing 22 exons spanning
approximately 18 kb. The targeting construct (middle line) was
designed to replace exon 1 through intron 1 with a neomycin resistance
gene (NEO). TK indicates the Herpes simplex thymidine kinase gene,
which with NEO allowed selection in a medium containing ganciclovir
(Ganc) and G418. The cloning vector is represented by a wavy line. The
bottom line shows the targeted locus. (B) A Western blot, using an
antibody against the extracellular domain of rat NPRA, of the
membrane fraction of kidney extracts prepared from Npr1 2y2
(homozygous mutant) and 1y1 (wild type) mice. The 135-kDa NPRA
protein, present in the wild-type mice but absent in the mutants, is
indicated, as is an unidentified cross-reacting protein of 97 kDa that
is equally present in mice of both genotypes. (C) An autoradiogram
showing the absence or presence of the 135-kDa NPRA after pho-
toaffinity labeling with 4-azidobenzoyl [125I]-ANP in plasma mem-
brane preparations of lung tissue from Npr1 2y2 and wild-type (1y1)
mice. The positions of the 135-kDa NPRA and 70-kDa natriuretic
peptide receptor C radiolabeled bands are indicated.
Medical Sciences: Oliver et al. Proc. Natl. Acad. Sci. USA 94 (1997) 14731
any group. Overall, these data demonstrate the importance of
NPRA in regulating blood pressure in both males and females.
The plasma renin concentration in our Npr1 2y2 mice was less
than one-third normal (28 6 5%; P , 0.01 by Student’s t test;
n 5 4), so that these animals provide a model of genetically
induced hypertension associated with low plasma renin con-
centration.
Cardiac Hypertrophy in the Mice Lacking NPRA. In hu-
mans, severe untreated hypertension typically progresses
through stages, including cardiac hypertrophy, left ventricular
dilatation, and an increased incidence of sudden death (20, 21).
The first (compensated) stage is an adaptive, hypertrophic
response of the heart muscle to the increased load. Although
this response is appropriate, it often progresses to later (de-
compensated) stages that can have severe consequences, as
indicated by the identification of left ventricular hypertrophy
as an independent risk factor for heart failure and cardiac
death associated with hypertension (22–24). We found that our
female mice lacking NPRA have an elevated heart-to-body
weight ratio averaging 133% of wild type (P , 0.01) by 3
months of age (Fig. 2B). A similar ratio of approximately 140%
of wild-type controls has been reported in animals lacking
ANP (8). Heart weights this much greater than controls could
be considered pathological in humans although they are within
the maximum limits seen in healthy athletes (up to approxi-
mately 170% of the normal average) (22). Hearts from the
Npr1 2y2 male mice were considerably more enlarged than in
the females, with heart-to-body weight ratios averaging 185%
that of wild-type males (P , 0.001). Cardiac hypertrophy of
this degree is indisputably pathological in humans and often is
accompanied by ventricular dilatation.
Echocardiographic and Hemodynamic Evaluation Shows
the Npr1 2y2 Hearts Are Fully Functional. To investigate
ventricular dilation, we used echocardiography (illustrated in
Fig. 3) to compare the in vivo cardiac functions of three male
and one female Npr1 2y2 mice between 4 and 5 months of age
with those of comparable wild-type mice. The resulting echo-
cardiographic data are shown in Table 1 together with the
weights of the individual heart chambers of the same animals.
Without exception, all of the Npr1 2y2 animals of both sexes
proved to have dilated ventricles, with a mean of more than
125% normal left ventricular end diastolic dimension (P ,
0.00005) and end systolic dimensions (P , 0.005). The mutant
mice used for the echocardiography had heart-to-body weight
ratios significantly greater than wild type (160% wild type),
and also left auricle-to-body weight ratios (250%), right auricle
(220%), right ventricle (160%), and left ventricle (150%), with
all P values being less than 0.005. However, despite the
hypertrophy and dilatation of the mutant hearts, they were still
capable of normal left ventricular performance under the
conditions of the echocardiography, as judged (Table 1) by the
fractional shortening of the left ventricular walls (% fractional
shortening, FS) and rate of wall shortening (velocity of cir-
cumferential fiber shortening, Vcf).
FIG. 2. Blood pressures, heart weights, and survivals of mutant and
wild-type mice. (A) Blood pressures as a function of Npr1 genotype
and dietary salt. Mean blood pressures measured by a noninvasive
computerized tail-cuff method in conscious young adult mice aged
95–115 days are shown for male (n 5 12 per genotype) and female (n 5
20 per genotype) Npr1 2y2 (solid bars) and 1y1 (open bars) animals
on a low (0.05% NaCl), intermediate (2% NaCl), or high (8% NaCl)
salt diet. SEMs are indicated above the bars. p, P , 0.001 vs. wild-type
controls by ANOVA. (B) Heart weights as a percent of total body
weight of 3-month-old mice. Individual values are represented as
squares (males) and circles (females), and mean values are indicated
by horizontal lines. p, P , 0.001 and †, P , 0.01 vs. wild-type controls
by two-tailed t test. (C) The percentage survival of male (M) and
female (F) Npr1 2y2 animals and wild-type (1y1) controls as a
function of age.
FIG. 3. M-mode echocardiographic tracings from an Npr1 1y1
and an Npr1 2y2 mouse. ECG, electrocardiogram; IVS, interven-
tricular septal wall; PW, posterior wall. The longer and shorter vertical
bars illustrate the left ventricular end diastolic and end systolic
dimensions, respectively. The ECG is used for timing purposes and,
because it is not calibrated, cannot be used to assess conduction
patterns.
Table 1. Echocardiographic and chamber weight findings in
Npr1-deficient mice
Npr1 1/1 (n 5 10) Npr1 2/2 (n 5 4)
BW (g) 28.19 6 0.69 29.62 6 1.37
LVEDD (mm) 3.82 6 0.08 4.89 6 10†
LVESD (mm) 2.43 6 0.11 3.06 6 0.08*
PWth (mm) 0.66 6 0.04 0.67 6 0.03
IVSth (mm) 0.65 6 0.04 0.66 6 0.02
FS (%) 36.6 6 1.9 37.3 6 1.10
HR (bpm) 273 6 21 253 6 26
Vcf (circ/s) 5.19 6 0.34 5.15 6 0.27
HW/BW (mg/g) 4.55 6 0.15 7.13 6 32†
LV/BW (mg/g) 3.30 6 0.11 4.89 6 0.28†
RV/BW (mg/g) 1.00 6 0.04 1.64 6 0.16*
LA/BW (mg/g) 0.13 6 0.01 0.32 6 0.03†
RA/BW (mg/g) 0.13 6 0.01 0.28 6 0.01†
Data expressed as mean 6 SE. BW, body weight; LVEDD, left
ventricular end diastolic dimension; LVESD, left ventricular end
systolic dimension; IVSth, interventricular septal wall thickness;
PWth, posterior wall thickness; HR, heart rate; FS, fractional short-
ening; Vcf, velocity of circumferential fiber shortening; HW, heart
weight; LV, left ventricle; RV, right ventricle; LA, left atrium; RA,
right atrium.
*P , 0.005.
†P , 0.00005 2/2 compared to 1/1, Student’s t test.
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A subsequent hemodynamic evaluation of the same Npr1 2y2
mice before and after challenge with an intravenous injection
of 1 ml of normal saline demonstrated that they had elevated
left ventricular systolic pressures under both basal and volume-
loaded conditions (171 6 21 mmHg and 213 6 21 mmHg,
respectively) compared with wild-type mice (116 6 6 mmHg
and 159 6 4 mmHg, both P values , 0.005) consistent with the
finding of elevated tail cuff blood pressure noted above. Their
unchallenged left ventricular end diastolic pressure (7.5 6 1.5
mmHg) did not differ from wild type (7.2 6 1.0 mmHg), and
the left ventricular end diastolic pressure in the 2y2 mice
after volume load was 16 6 4 mmHg compared with 22 6 2
mmHg in 1y1 mice. Thus, the Npr1 2y2 mice appear able to
handle an increase in filling pressure as well as wild-type
animals. This ability is confirmed by our finding that the
maximum change in left ventricular pressure, dPydtmax (a
measure of ventricular contractility), in the mutants (14.2 6
3.4 3 103 mmHgysec) was in fact greater than that in the
FIG. 4. Histological analysis of tissues from Npr1 2y2 male mice and wild-type controls. (A–E) Heart tissues from euthanized animals
stained with Masson’s trichrome. Hearts were fixed without diastole arrest and with no intracardiac pressure, consequently the in vivo dilatation
of the Npr1 2y2 hearts was not preserved. (A) 39 and (C) 3175 magnification of transverse sections of the heart from a 3.5-month-old wild-type
male. (B) 39 and (D) 3175 magnification of sections from a 3.5-month-old Npr1 2y2 male. Fibrotic regions stain blue. (E) 3175 magnification
of a section of a 4-month-old Npr1 2y2 male showing dying myocytes (blue). (F) 345 magnification of the aortic dissection from a deceased
3.5-month-old Npr1 2y2 male, stained with trichrome-elastin stain to show elastic and connective tissue. The platelet-fibrin strands in the clot in
the lower left quadrant show that some bleeding had occurred before death of the mouse.
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wild-type animals (8.2 6 0.6 3 103 mmHgysec). Overall, the
heart weight, and echocardiographic and hemodynamic data of
these 4- to 5-month-old mutants are consistent with a com-
pensated state of systemic hypertension accompanied by
marked cardiac hypertrophy and ventricular enlargement with
no evidence of myocardial dysfunction.
Sudden Death in the Npr1 2y2 Male Mice. Extensive
hypertrophy in humans often is associated with local ischemia
in the hypertrophic myocardium that leads to death of some
myocytes and to patchy fibrosis. To assess if pathological
changes were occurring in the hearts of the Npr1 2y2 animals,
we sacrificed four mutant males (3 to 5 months of age), five
mutant females (6 months of age), and equal numbers of
age-matched wild-type animals. Fig. 4 A and B compare
ventricular cross sections from a wild-type control and a male
Npr1 2y2 mutant and illustrate a marked concentric hyper-
trophy in the mutant mice. Histological (Fig. 4 C and D) and
morphometric comparisons show that this hypertrophy is
paralleled by an increase in the myocyte cross-sectional area
which in the male mutants averages more than 200% normal
(213% 6 32%). Perivascular fibrosis (Fig. 4D) was seen in all
four Npr1 2y2 males examined, although the extent of this
scarring was somewhat variable. In addition, we observed
patchy areas of incipient myocyte death in the ventricles of
some of the mutant males (Fig. 4E). The degree of cardiac
hypertrophy and fibrosis was lower in female mutants than in
males, with fibrotic foci observed in all four males but in only
one of the five females examined. Histological evaluations of
the lungs and kidneys of the Npr1 2y2 mice were unremark-
able.
Differences in the degree of pathological changes in the
male and female Npr1 2y2 mice are further emphasized by
comparing their survivals. Thus, as illustrated in Fig. 3C, all 15
male but only one of 16 female mutants died before 6 months
of age. No wild-type mice died. Initially we had noticed that
seven of seven male Npr1 2y2 mice housed with litter mates
died between 7 and 8 weeks of age, whereas one that was
housed alone survived. At this point all 2y2 males were
housed alone except during some ongoing behavioral tests.
However, beginning at about 9 weeks, deaths still occurred.
The lethal incidents may be precipitated by stress. For exam-
ple, one animal died on an exercise wheel after prolonged
voluntary exercise at night; others died after being placed with
other males, or while on the high-salt diet. Necropsy was
performed on as many of the animals as possible within 24 hr
of death. Of eight animals examined, four had congested hearts
and lungs; there was no evidence of gross abnormalities in
other organs such as the kidneys. Three animals had aortic
dissections (Fig. 4F). One animal died with external bleeding,
the source of which was not discernible; this animal also had
a pulmonary artery luminal inclusion likely to have resulted
from pulmonary embolism. Evidence of death from cerebral
hemorrhage was not observed in any of the eight animals.
Exactly what precipitates the lethal events remains to be
determined. However, cardiac output and basal stroke work
calculations from the echocardiography and hemodynamic
data suggest that the hearts of the mutants are working at least
twice as hard as those of the wild-type animals. Thus, even
under nonstressed conditions, the mutant myocardium has
much greater oxygen demands than normal. A relatively small
increase in demand therefore may stress the mutant hearts to
the point of failure. Death also may be precipitated by sudden
surges of blood pressure during conditions of stress, as sug-
gested by the three cases of aortic dissection. It is important,
therefore, to explore the possibility that genotype- and gender-
related differences in blood pressures are enhanced when the
Npr1 2y2 animals are stressed or during the night when mice
are normally active.
Npr12y2 Mice Provide a Unique Model for Hypertensive
Heart Disease. The occurrence of marked hypertrophy and
sudden cardiovascular death in our Npr1 2y2 mutants in the
absence of clear evidence of cardiac dysfunction is one of their
most intriguing aspects and makes them unique. Although
NPRA-deficient mice with a similar degree of hypertension
have been reported by Lopez et al. (10), the hearts, kidneys,
and vasculature of their mutants (carrying a simple insertion
of a neomycin-resistance gene into exon 4 of the Npr1 gene)
were normal when examined by histological methods at less
than 5 months of age; no increase in postnatal mortality was
reported. Likewise, sudden death from cardiovascular events
was not observed in other mice with similar hypertension
induced by, for example, a genetic increase in angiotensinogen
(18) or by a genetic absence of endothelial nitric oxide synthase
(25, 26). In this context it is noteworthy that the steady-state
levels of ANP and its mRNA increase more than 20-fold in the
mouse ventricular myocardium in response to pressure over-
load caused by banding the thoracic aorta (27). Possibly a
normal natriuretic peptide system acts locally to moderate the
hypertrophy induced by hypertension.
In conclusion, we have observed in the Npr1 2y2 mice many
of the features of hypertensive heart disease seen in untreated
human patients, including an initial compensated cardiac
hypertrophy, chamber enlargement, and myocyte death, fol-
lowed by lethal incidents possibly precipitated by stress. The
relevance of decreases in the function of NPRA specifically
to human patients must await further work. Meanwhile the
Npr1 2y2 mice described here provide a genetically well-
defined animal model likely to be of considerable value in
attempts to understand and moderate the progression of a
lethal form of hypertension.
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